Position in NBIX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,528
+$552 QoQ
Shares Held
15
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#724
of 768 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MidFirst Bank holds $1,332,303 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
18,279 | $1,313,528 | |
| 2 | VTRS |
Viatris Inc
|
377 | $5,986 | |
| 3 | HLN |
Haleon plc
|
597 | $5,570 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
5 | $2,709 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
15 | $2,528 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
38 | $1,287 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
24 | $384 | |
| 8 | PRGO |
PERRIGO Co plc
|
30 | $311 |
All Filings in NBIX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,528 | 15 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,976 | 15 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,127 | 1,239 | Shares | Sole | 2026-02-25 | |
| No filing history on record for this holder in this stock. | ||||||